Thinking of joining a study?

Register your interest

NCT06735469 | NOT YET RECRUITING | Clinical Trials


Clinical Trial Preference Study
Sponsor:

Rush University Medical Center

Information provided by (Responsible Party):

Melissa M. Crane, PhD

Brief Summary:

Population subgroups experiencing health disparities are often also underrepresented in clinical trials. These groups include individuals from minoritized racial and ethnic groups, people from lower socioeconomic backgrounds, and men or women, depending on the study area. Identifying approaches to reduce health disparities will remain stalled until clinical trials can recruit and retain diverse clinical trial participants. To improve recruitment across studies, there is a need to understand how diverse populations view specific clinical trial attributes that could be manipulated to increase interest in trials. To address this need, this project will use a discrete choice experiment to identify and prioritize specific trial attributes under investigators' control that could be leveraged to enhance clinical trial participation rates in underrepresented groups. This project will evaluate participants' preferences of 1) return of full versus limited results to participants, 2) balancing a study's participant burden with its ability to address multiple research aims, 3) incentivizing clinical assessments vs. conducting homebased assessments, and 4) results generalizable to specific social groups versus the broader population. This experiment will be conducted with a sample of potential clinical trial participants (N = 800) that is diverse in terms of self-reported gender, racial and ethnic identity, education, and chronic disease status. The results of this study will be used to design a randomized comparison of enhanced clinical trial attributes across multiple health conditions to evaluate whether using the enhanced trial features can more efficiently recruit underrepresented participants into clinical trials.

Condition or disease

Clinical Trials

Intervention/treatment

Discrete choice experiment

Study Type : OBSERVATIONAL
Estimated Enrollment : 800 participants
Official Title : Leveraging Discrete Choice Experiments to Increase Participant Diversity in Future Clinical Trials
Actual Study Start Date : 2025-05-01
Estimated Primary Completion Date : 2025-09-01
Estimated Study Completion Date : 2025-09-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * Internet access with audio and visual capabilities
  • * Reside within the United States
  • * Read and speak English
Exclusion Criteria
  • * Under 18 years of age
  • * No internet access
  • * Reside outside of the United States
  • * Do not read and speak English

Clinical Trial Preference Study

Location Details

NCT06735469


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, Illinois

Rush University Medical Center

Chicago, Illinois, United States, 60612

Loading...